APPLICATION OF HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF LEVODOPA, CARBIDOPA, AND ENTACAPONE IN TABLET DOSAGE FORMS

REFERENCES

• European Pharmacopoeia; 6th Ed; Levodopa, Ph Eur Monograph 0038, (EDQM), 2008; 2258–2260 .
   Google Scholar
• European Pharmacopoeia; 6th Ed; Carbidopa, Ph Eur Monograph 0755, (EDQM), 2008; 1314–1414 .
   Google Scholar
• http://www.chemblink.com/products/130929-57-6.htm (accessed June 2008)
   Google Scholar
• Novartis Pharmaceuticals Corporation. FDA Approves Stalevo for Treatment of Parkinson's Disease. Media Release: 13 Jun 2003. Available from URL: http://www.novartis.com (accessed Jun 2003)
   Google Scholar
• Novartis Pharmaceuticals Corporation. FDA ApproveOrion Corporation. Orion Group Interim Report 1-6/2003. MediaRelease: URL: http://www.o-rion.fi. Available from (6 Aug 2003)
   Google Scholar
• Paim , C. S. ; Goncalves , H. ; Lange , A. ; Miron , D. ; Steppe , M. Validation of UV Spectrophotometric Method for Quantitative Determination of Entacapone in Tablets Using Experimental Design of Plackett-Burman for Robustness Evaluation and Comparison with HPLC . Anal. Lett. 2008 , 41 , 571 – 581 .
   Web of Science ®Google Scholar
• Issopoulos , P. B. ; Fresenius , J. High-Sensitivity Spectrophotometric Determination of Trace Amounts of Levodopa, Carbidopa and Methyldopa . J. Anal. Chem. 1990 , 336 ( 2 ), 124 – 128 .
   Web of Science ®Google Scholar
• Damiani , P. C. ; Moschetti , A. C. ; Rovetto , A. J. ; Benavente , F. ; Olivieri , A. C. Design and Optimization of a Chemometrics-Assisted Spectrophotometric Method for the Simultaneous Determination of Levodopa and Carbidopa in Pharmaceutical Products . Anal. Chem. Acta. 2005 , 543 ( 1–2 ), 192 – 198 .
   Web of Science ®Google Scholar
• Steup , A. ; Metzner , J. ; Voll , A. Simple Photometric Method for Determination of Levodopa and Carbidopa in Pharmaceutical Preparations . Pharmazie. 1986 , 41 ( 10 ), 739 .
   PubMed Web of Science ®Google Scholar
• Issopoulos , P. B. Spectrophotometric Determination of Micro Quantities of Carbidopa, Levodopa and Alpha-Methyldopa Using Molybdophosphoric Acid . Pharm. Acta. Helv. 1989 , 64 ( 3 ), 82 – 85 .
   PubMedGoogle Scholar
• Issopoulos , P. B. Sensitive Colorimetric Assay of Carbidopa and Methyldopa Using Tetrazolium Blue Chloride in Pharmaceutical Products . Pharm. Weekbl, Sci. 1989 , 11 ( 6 ), 213 – 217 .
   PubMedGoogle Scholar
• Fanali , S. ; Pucci , V. ; Sabbioni , C. ; Raggi , M. A. Quality Control of Benserazide/Levodopa and Carbidopa/Levodopa Tablets by Capillary Zone Electrophoresis . Electrophoresis. 2000 , 21 ( 12 ), 2432 – 2437 .
   PubMed Web of Science ®Google Scholar
• Zhang , L. ; Chen , G. N. ; Hu , Q. ; Fang , Y. Z. Separation and Determination of Levodopa and Carbidopa in Composite Tablets By Capillary Zone Electrophoresis with Amperometric Detection . Anal. Chim. Acta. 2001 , 431 ( 2 ), 287 – 292 .
   Web of Science ®Google Scholar
• Sagar , K. A. ; Smyth , M. R. Bioavailability Studies of Oral Dosage Forms Containing Levodopa and Carbidopa Using Column-Switching Chromatography Followed by Electrochemical Detection . Analyst (Cambridge, UK). 2000 , 125 ( 3 ), 439 – 445 .
   PubMed Web of Science ®Google Scholar
• Rihbany , L. A. ; Delaney , M. F. Determination of Impurities in Levodopa and Carbidopa by High-Performance Liquid Chromatography with Electrochemical Detection . J. Chromatogr. 1982 , 248 ( 1 ), 125 – 133 .
   Web of Science ®Google Scholar
• Ting , S. J. Liquid-Chromatographic Determination of Levodopa, Carbidopa and Related Impurities in Solid Dosage Forms . J. AOAC. 1986 , 69 ( 1 ), 169 – 173 .
   Google Scholar
• Michotte , Y. ; Moors , M. ; Deleu , D. ; Herregodts , P. ; Ebinger , G. Simultaneous Determination of Levodopa, Carbidopa, o-3-methyldopa and Dopamine in Plasma Using High-Performance Liquid Chromatography with Electrochemical Detection . J. Pharma. Biomed. Anal. 1987 , 5 ( 7 ), 659 – 664 .
   PubMed Web of Science ®Google Scholar
• Cedarbaum , J. M. ; Williamson , R. ; Kutt , H. Simultaneous Determination of Levodopa, Its Metabolites and Carbidopa in Clinical Samples . J. Chromatogr. Biomed. Appl. 1987 , 59 ( 2 ), 393 – 399 .
   Google Scholar
• Ting , S. Liquid-Chromatographic Determination of Levodopa and Levodopa-Carbidopa in Solid Dosage Forms: Collaborative Study . J. AOAC. 1987 , 70 ( 6 ), 987 – 990 .
   Google Scholar
• Miller , R. B. ; Dehelean , L. ; Belanger , L. Determination of Carbidopa and Levodopa in Human Plasma by High-Performance Liquid Chromatography with Electrochemical Detection . Chromatographia. 1993 , 35 ( 9–12 ), 607 – 661 .
   Web of Science ®Google Scholar
• Tolokan , A. ; Klebovich , I. ; Nemes , K. B. ; Horavil , G. Automated Determination of Levodopa and Carbidopa in plasma by High-Performance Liquid Chromatography-Electrochemical Detection Using an Online Flow-Injection Analysis Sample Pretreatment Unit . J. Chromatogr, B 1997 , 698 ( 1–2 ), 201 – 207 .
   PubMedGoogle Scholar
• Smyth , M. R. ; Sagar , K. A. Simultaneous Determination of Levodopa, Carbidopa and Their Metabolites in Human Plasma and Urine Samples Using LC with Amperometric Detection . J. Pharm. Biomed. Anal. 2000 , 22 ( 3 ), 613 – 624 .
   PubMed Web of Science ®Google Scholar
• Karimi , M. ; Carl , J. L. ; Loftin , S. ; Perlmutter , J. S. Modified HPLC with Electrochemical Detection Method for Plasma Measurement of Levodopa, 3-o-methyldopa, Dopamine, Carbidopa, and 3,4-dihydroxyphenyl Acetic Acid . J. Chromatogr, B 2006 , 836 ( 1–2 ), 120 – 123 .
   PubMed Web of Science ®Google Scholar
• Doshi , A. S. ; Upadhyay , K. J. ; Mehta , T. N. ; Nada , N. Application of HPLC Method for Determination of Levodopa, Carbidopa, and Entacapone in Tablet Dosage Form. J. AOAC. 2009, 92 (2), 394–402.
   PubMed Web of Science ®Google Scholar
• U.S. Pharmacopoeia, thirty four Ed. 2011, Dissolution chapter 711, Vol. 1, 278–285 .
   Google Scholar
• ICH, Topic Q2A-Note for Guidance on Validation of Analytical Methods: Definitions and Terminology (CPMP-ICH-381-95) and Topic Q2B-Note for Guidance on Validation of Analytical Procedures: Methodology (CPMP-ICH-281-95), International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1995.
   Google Scholar